전일 마감가:
$880.50
열려 있는:
$883.02
하루 거래량:
593.00K
Relative Volume:
0.61
시가총액:
$101.36B
수익:
$403.43B
순이익/손실:
$5.10B
주가수익비율:
22.60
EPS:
38.4657
순현금흐름:
$5.41B
1주 성능:
-1.16%
1개월 성능:
-0.51%
6개월 성능:
-1.43%
1년 성능:
+14.30%
맥케슨 Stock (MCK) Company Profile
명칭
Mckesson Corp
전화
972-446-4800
주소
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
MCK
Mckesson Corp
|
869.36 | 102.66B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
309.87 | 59.59B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
222.62 | 51.24B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
85.53 | 9.48B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
0.76 | 659.58M | 14.85M | -136.07M | 7.25M | -0.4726 |
맥케슨 Stock (MCK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2024-12-04 | 재개 | Mizuho | Neutral |
| 2024-11-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 재확인 | Leerink Partners | Outperform |
| 2024-08-08 | 재확인 | Mizuho | Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-07-06 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 재확인 | Barclays | Overweight |
| 2021-11-02 | 재확인 | BofA Securities | Buy |
| 2021-11-02 | 재확인 | Evercore ISI | Outperform |
| 2021-11-02 | 재확인 | Jefferies | Buy |
| 2021-03-30 | 업그레이드 | Argus | Hold → Buy |
| 2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-08-04 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-05-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-03-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-05 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 개시 | Guggenheim | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-10-26 | 재확인 | Barclays | Equal Weight |
| 2018-07-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Equal Weight |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-02 | 재확인 | Mizuho | Neutral |
| 2018-01-24 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
맥케슨 주식(MCK)의 최신 뉴스
McKesson 5-year return hits 34.23%, beating market by 22.21% - scanx.trade
Here’s How Much You Would Have Made Owning McKesson Stock In The Last 5 Years - benzinga.com
Cardinal Health vs. McKesson: Which Healthcare Stock Is Better? - uk.finance.yahoo.com
Why McKesson (MCK) Dipped More Than Broader Market Today - finance.yahoo.com
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date - finance.yahoo.com
McKesson stock heads into the open after a 1.3% gain - ad-hoc-news.de
McKesson Corp. stock rises Monday, still underperforms market - MarketWatch
Dig: Precision Medicine Group McKesson ACQ premature (not closed) - Dealroom
McKesson stock heads into the open after a 1.5 percent slide - ad-hoc-news.de
Why Is McKesson (MCK) a Stock to Watch Today? - Kalkine Media
McKesson Cyberattack: Stolen Data Includes 6.4 Million Unique Email Addresses - The HIPAA Journal
Mckesson Stock Price Forecast. Should You Buy MCK? - StockInvest.us
6.4 Million Email Addresses Exposed in McKesson Hack - BankInfoSecurity
Mckesson Corp. (0JZU) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Mckesson Corp. (0JZU) Q4 2026 Earnings ReportResults, Call & Slides - TipRanks
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Mckesson Corp. (0JZU) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
McKesson Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong - finance.yahoo.com
A Look at McKesson Corp (MCK) After 3.3% Gain -- GF Value $829.6 - GuruFocus
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal - Yahoo Finance
Lawsuits Over McKesson Voice-Phishing Attack Points to Ongoing Risk in Healthcare Sector - Law.com
McKesson stock heads into the open after a 1.2% drop - ad-hoc-news.de
McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson Corp (MCK) Insider Sale: SVP, Controller & CAO Rutledge Napoleon B JR Sells 111 Shares - GuruFocus
McKesson (MCK) Plans A $2.25b Deal, Is The Stock Fully Valued? - simplywall.st
McKesson Senior VP Napoleon Rutledge Jr. Sells 111 Shares via 10b5-1 Trading Plan - Kalkine Media
ShinyHunters expose 6.4M in attack on medical supplier McKesson - The Register
Why Is McKesson (NYSE:MCK) Stock In Focus Today? - Kalkine Media
McKesson (NYSE:MCK): Is the Cyber Risk Overpriced? - Kalkine Media
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates - Yahoo Finance
McKesson at wells fargo healthcare conference: growth, deal push - investing.com
McKesson Corp's negligence caused a data breach, a new class action lawsuit claims - claimdepot.com
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Zacks Investment Research
McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy - Yahoo Finance
McKesson Stock (MCK) Opinions on Recent Data Leak and Market Dynamics - Quiver Quantitative
McKesson Owns Antitrust Claims, Not Rite Aid, Judge Finds - Law360
McKesson Corp. stock underperforms Friday when compared to competitors - MarketWatch
McKesson Corp (MCK) Stock Price, Quote, News & History - Benzinga
McKesson Data Breach: Investigation Ongoing - Claim Depot
Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report? - finance.yahoo.com
McKesson Stock: Is MCK Outperforming the Healthcare Sector? - Barchart.com
Mckesson Corporation (MCK) News, Articles, Events & Latest Updates - Stocktwits
McKesson confirms data theft in cyberattack involving third-party apps - finance.yahoo.com
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Sep 1: Key Drivers Unveiled - tradingkey.com
McKesson data breach exposes prescribing physicians and their patients to fallout from a third-party attack - Medical Economics
맥케슨 (MCK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):